. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol. 2000 Oct;48(4):567-79. PubMed.


Please login to recommend the paper.


Make a Comment

To make a comment you must login or register.

Comments on this content

  1. These add strong support to the notion that therapy targeting amyloid-beta may be an effective treatment for Alzheimer's disease.

  2. Please see the following comments related to this article:

    Alzheimer’s anti-amyloid vaccination and statins: two approaches, one dogma. The time for change.
    Koudinov and Koudinova
    BMJ 20 March 2002 [ Full Text ]

    Alzheimer's disease and amyloid beta protein
    Koudinov AR et al
    Science online,> Published 25 June 2002
    [ Full Text ]

    Dangers of the amyloid-beta vaccination.
    Smith MA et al.
    Acta Neuropathol (Berl) 2002 Jul;104(1):110 [
    PubMed ]

    Call for Elan to publish Alzheimer's trial details
    Bishop et al.
    Nature. 416(6882): 677, 2002 Apr 18. [ PubMed ]

This paper appears in the following:


  1. A Sniffable Vaccine?